Evidence map›Paper›PMID 33727149›Full record

ArticleMagnetic resonance imaging2021

Chest MRI of patients with COVID-19.

Yu A Vasilev, K A Sergunova, A V Bazhin, A G Masri, Yu N Vasileva, D S Semenov, N D Kudryavtsev, O Yu Panina, A N Khoruzhaya, V V Zinchenko and 5 more

Open access · greenAbstract read
In one paragraph

Article in Magnetic resonance imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. COVID-19 diagnostics: Molecular biology to nanomaterials.Clinica chimica acta; international journal of clinical chemistry · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Yu A VasilevResearch and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Healthcare Department, Moscow, Russia.
K A SergunovaResearch and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Healthcare Department, Moscow, Russia. Electronic address: kristi.sergunova@gmail.com.
A V BazhinResearch and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Healthcare Department, Moscow, Russia. Electronic address: avbazhin@yandex.ru.
A G MasriImed Clinic, Grozny, Chechen Republic, Russia. Electronic address: amir.masri6@gmail.com.
Yu N VasilevaA.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia. Electronic address: drugya@yandex.ru.
D S SemenovResearch and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Healthcare Department, Moscow, Russia. Electronic address: d.semenov@npcmr.ru.
N D KudryavtsevResearch and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Healthcare Department, Moscow, Russia. Electronic address: n.kudryavtsev@npcmr.ru.
O Yu PaninaResearch and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Healthcare Department, Moscow, Russia. Electronic address: olgayurpanina@gmail.com.
A N KhoruzhayaResearch and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Healthcare Department, Moscow, Russia. Electronic address: a.khoruzhaya@npcmr.ru.
V V ZinchenkoResearch and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Healthcare Department, Moscow, Russia. Electronic address: v.zinchenko@npcmr.ru.
E S AkhmadResearch and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Healthcare Department, Moscow, Russia. Electronic address: e.ahmad@npcmr.ru.
A V PetraikinResearch and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Healthcare Department, Moscow, Russia. Electronic address: alexeypetraikin@gmail.com.
A V VladzymyrskyyResearch and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Healthcare Department, Moscow, Russia. Electronic address: a.vladzimirsky@npcmr.ru.
A V MidaevImed Clinic, Grozny, Chechen Republic, Russia. Electronic address: amidaev@list.ru.
S P MorozovResearch and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Healthcare Department, Moscow, Russia. Electronic address: morozov@npcmr.ru.
Russian Research Center for Molecular Diagnostics and Therapy · RUMoscow State University of Medicine and Dentistry · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the pandemic of novel coronavirus infection (COVID-19), computed tomography (CT) showed its effectiveness in diagnosis of coronavirus infection. However, ionizing radiation during CT studies causes concern for patients who require dynamic observation, as well as for examination of children and young people. For this retrospective study, we included 15 suspected for COVID-19 patients who were hospitalized in April 2020, Russia. There were 4 adults with positive polymerase chain reaction (PCR) test for COVID-19. All patients underwent magnetic resonance imaging (MRI) examinations using MR-LUND PROTOCOL: Single-shot Fast Spin Echo (SSFSE), LAVA 3D and IDEAL 3D, Echo-planar imaging (EPI) diffusion-weighted imaging (DWI) and Fast Spin Echo (FSE) T2 weighted imaging (T2WI). On T2WI changes were identified in 9 (60,0%) patients, on DWI - in 5 (33,3%) patients. In 5 (33,3%) patients lesions of the parenchyma were visualized on T2WI and DWI simultaneously. At the same time, 4 (26.7%) patients had changes in lung tissue only on T2WI. (P(McNemar) = 0,125; OR = 0,00 (95%); kappa = 0,500). In those patients who had CT scan, the changes were comparable to MRI. The results showed that in case of CT is not available, it is advisable to conduct a chest MRI for patients with suspected or confirmed COVID-19. Considering that T2WI is a fluid-sensitive sequence, if imaging for the lung infiltration is required, we can recommend the abbreviated MRI protocol consisting of T2 and T1 WI. These data may be applicable for interpreting other studies, such as thoracic spine MRI, detecting signs of viral pneumonia of asymptomatic patients. MRI can detect features of viral pneumonia.

Indexed as

Magnetic Resonance ImagingAdolescentAdultAgedChildCOVID-19HumansLungMaleMiddle AgedRetrospective StudiesYoung AdultChest MRIComputed tomographyCOVID-19Magnetic resonance imagingPneumonia

Identifiers

PMID33727149
PMCPMC7955570
OpenAlexW3137167625

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.